More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Among the research grants, Taimalieutu Kiwi Tamasese from The Family Centre has been awarded $80,000 in funding to lead a study on gout within Pasifika communities living in the Wellington and ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...

Autoimmune disorders in children can cause symptoms often mistaken for common childhood illnesses. More precise diagnoses and ...

On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders.

found that 27% of individuals with systemic lupus erythematosus (SLE) had hearing loss. This was significantly higher than in the control group. Participants with SLE showed worse hearing at lower ...

The 2019 EULAR/ACR systemic lupus erythematosus classification criteria were not predictive of mortality or hospitalization. While the 2019 European Alliance of Associations for Rheumatology ...